INR 910.0
(-0.9%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 568.37 Million INR | -8.49% |
2022 | 621.11 Million INR | -9.18% |
2021 | 683.88 Million INR | -63.02% |
2020 | 1.84 Billion INR | 265.19% |
2019 | -1.11 Billion INR | -92.83% |
2018 | -580.57 Million INR | 3.49% |
2017 | -601.57 Million INR | -1432.78% |
2016 | -39.24 Million INR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 195.96 Million INR | 9.35% |
2024 Q1 | 179.21 Million INR | -4.29% |
2023 Q3 | 129.74 Million INR | 23.61% |
2023 Q4 | 187.25 Million INR | 44.33% |
2023 FY | 568.37 Million INR | -8.49% |
2023 Q1 | 146.43 Million INR | -22.6% |
2023 Q2 | 104.96 Million INR | -28.32% |
2022 Q1 | 142.15 Million INR | -20.75% |
2022 Q4 | 189.18 Million INR | 38.67% |
2022 FY | 621.11 Million INR | -9.18% |
2022 Q3 | 136.42 Million INR | -11.06% |
2022 Q2 | 153.38 Million INR | 7.9% |
2021 Q1 | 215.95 Million INR | 296.3% |
2021 FY | 683.88 Million INR | -63.02% |
2021 Q4 | 179.37 Million INR | 9.83% |
2021 Q3 | 163.32 Million INR | 30.38% |
2021 Q2 | 125.26 Million INR | -42.0% |
2020 FY | 1.84 Billion INR | 265.19% |
2020 Q4 | -110.01 Million INR | 0.0% |
2019 FY | -1.11 Billion INR | -92.83% |
2019 Q4 | -652.61 Million INR | 0.0% |
2018 FY | -580.57 Million INR | 3.49% |
2017 FY | -601.57 Million INR | -1432.78% |
2016 FY | -39.24 Million INR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Dr. Lal PathLabs Limited | 3.57 Billion INR | 84.112% |
Metropolis Healthcare Limited | 1.27 Billion INR | 55.532% |
Thyrocare Technologies Limited | 707.6 Million INR | 19.676% |
Vijaya Diagnostic Centre Limited | 1.18 Billion INR | 52.168% |
Vimta Labs Limited | 410.09 Million INR | -38.596% |